hypertension
Digital chronic disease management company Omada Health announced today the launch of new programs designed to support individuals with Type 2 diabetes and hypertension.
A recent study of hypertension patients suggests follow-up visits conducted virtually are just as effective in maintaining blood pressure control as those conducted in person.
A recently published study in the New England Journal of Medicine shows that 24-hour ambulatory blood pressure monitoring is a better predictor of cardiovascular and all-cause mortality than just monitoring blood pressure in the clinic.
A study published in JAMA Internal Medicine today demonstrated that a smartphone app could lead to small improvements in self-reported medication adherence among participants with poorly controlled hypertension.
Redwood City, California-based Proteus Digital Health announced its first US healthcare provider customer, Barton Health, which will prescribe the company's Proteus Discover to patients.
Tactio Health Group, a Montreal-based company that builds smartphone-connected remote patient monitoring devices, will run a 25-person pilot study with the University of Michigan Health System, studying the effects of pharmacist-led home blood pressure monitoring and medication reminders on people with hypertension.
Example of a connected blood pressure device from iHealth.
Norwalk, Connecticut-based medication adherence platform company HealthPrize says it has succeeded in raising medication adherence an average of 54 percent across a series of pharma-sponsored pilot programs for various medical conditions, with sample sizes ranging from 250 to more than 7,000.